MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

23 Nov 2021 Evaluate

Alembic Pharmaceuticals has informed the exchange that the company has received US Food & Drug Administration (USFDA) Final Approval for Formoterol Fumarate Inhalation Solution, 20 mcg/2 ml per Unit-Dose Vial. In this regard, the company has attached a press release on November 23rd, 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..